Menu

Birds Warn Unborn Chicks About Warmer Weather

Zebra finches sing a special song that appears to help their offspring better adapt to a hotter climate, according to a study.

Aug 22, 2016
Alison F. Takemura

PIXABAY, JPROHASZKAZebra finch parents seem keenly aware of the weather during the last few days of incubating their eggs. And if it’s warmer than usual, they let their unborn chicks know. In a study published last week (August 19) in Science, researchers from Deakin University in Victoria, Australia, have shown that the birds croon a special song that seems to trigger changes in their chicks’ development. The chicks grow more slowly and, as adults, have more offspring of their own, the researchers showed.

“That’s a strategy we really didn’t know birds could do, and that could potentially help them deal with global warming,” study coauthor Mylene Mariette of Deakin told New Scientist.

Zebra finches are adept vocalists; mates often call to one another as they share parental care. But Mariette noticed that, sometimes, just a few days before their offspring hatched, the birds would sing when they were alone with the eggs, she told the BBC. The birds performed one particular song only during warm weather (above around 78 °F), she observed.

To examine the effects of this call, Mariette and her colleague Katherine Buchanan, also at Deakin, experimentally controlled the sounds that dozens of eggs heard, New Scientist reported. For three to five days before the eggs hatched, the scientists incubated them in warm conditions—around 100 °F—and played them socialization songs. For one group of unborn chicks, they also played the “heat call.”

Chicks primed with their parents’ hot-weather warnings grew more slowly and weighed less as they matured than did those that hadn’t heard the special song, Mariette and Buchanan found.

And the slower-developing offspring were more fit. The females that were primed for warmer weather had up to six fledglings in their first breeding season, whereas those that were not tended to have only one or two, New Scientist reported.

The fitness advantage may stem in part from the benefit of having a smaller size for more effective heat loss in a warmer climate, the authors wrote.

Whether developing avian embryos are directly affected by a song remains a mystery. “They’re not actually thinking, ‘Mum says it’s hot out there, I better take it slow when I get outside!’” Nicola Hemmings, who studies bird reproduction at Sheffield University in the U.K. and was not involved in the work, told the BBC. “But [this song is] having some kind of physiological effect on their body which is making their growth rate slow.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.